Board meeting to approve Q2 and half-year results
NH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.4 pts more than Nifty Midcap 150 and 1.9 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board will meet on October 30, 2026, to approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. No financial figures have been disclosed yet.
The upcoming results could affect investor sentiment and the share price, but performance details are not yet available.